Her primary areas of study are Pathology, Dementia, Internal medicine, Alzheimer's disease and Frontotemporal lobar degeneration. Her studies in Pathology integrate themes in fields like Hippocampal formation and White matter. Her Dementia research is within the category of Disease.
Her Internal medicine study deals with Oncology intersecting with Biomarker. Her Alzheimer's disease research includes themes of Cerebrospinal fluid, Cognition, Cognitive impairment, Corticobasal degeneration and Prospective cohort study. In her research on the topic of Frontotemporal lobar degeneration, Pathological, Motor neuron and Frontotemporal dementia is strongly related with Amyotrophic lateral sclerosis.
The scientist’s investigation covers issues in Internal medicine, Dementia, Pathology, Disease and Cognition. Her Internal medicine study frequently links to other fields, such as Oncology. Her Dementia research incorporates themes from Gerontology, Audiology, Psychiatry, Parkinson's disease and Alzheimer's disease.
Her Psychiatry research is multidisciplinary, incorporating elements of Prospective cohort study and Rating scale. Her study in the field of Cognitive reserve, Cognitive impairment and Lewy body is also linked to topics like Context. Her work deals with themes such as Activities of daily living, Clinical psychology and Cognitive decline, which intersect with Cognition.
Her main research concerns Internal medicine, Cognition, Cognitive decline, Dementia and Pathology. Her Internal medicine study frequently draws connections between adjacent fields such as Oncology. Her Cognition research is multidisciplinary, relying on both Parkinson's disease and Clinical psychology.
In her research, Mood disorders, REM sleep behavior disorder, Geriatric Depression Scale, State-Trait Anxiety Inventory and REM Sleep Behavior Disorder Screening Questionnaire is intimately related to Montreal Cognitive Assessment, which falls under the overarching field of Cognitive decline. Her biological study spans a wide range of topics, including Single-nucleotide polymorphism and Hyperintensity. Her research on Pathology often connects related topics like Luxol fast blue stain.
Sharon X. Xie focuses on Cognitive decline, Cognition, Specialty, Intensive care and Family medicine. Her Cognitive decline study combines topics from a wide range of disciplines, such as White matter, Neuropsychology, Posterior cortical atrophy, Middle frontal gyrus and Atrophy. The various areas that Sharon X. Xie examines in her Cognition study include Clinical psychology, Dementia and Fluency.
Her research integrates issues of Physical medicine and rehabilitation, Brain magnetic resonance imaging and Cognitive impairment in her study of Dementia. Her Specialty research incorporates elements of Epidemiology and Resident physician. Her studies deal with areas such as Cross-sectional study and Residency program as well as Intensive care.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial.
Gregory K. Brown;Thomas Ten Have;Gregg R. Henriques;Sharon X. Xie.
JAMA (2005)
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
S. Hoops;S. Nazem;A. D. Siderowf;J. E. Duda.
Neurology (2009)
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
Jon B. Toledo;Steven E. Arnold;Kevin Raible;Johannes Brettschneider.
Brain (2013)
Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model
Bin Zhang;Arpita Maiti;Sharon Shively;Fara Lakhani.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Cerebrospinal Fluid Tau and β-Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?
Christopher M. Clark;Sharon Xie;Jesse Chittams;Douglas Ewbank.
JAMA Neurology (2003)
Neuropathologic substrates of Parkinson disease dementia.
David J. Irwin;Matthew T. White;Jon B. Toledo;Sharon X. Xie.
Annals of Neurology (2012)
The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
Bin Zhang;Jenna Carroll;John Q. Trojanowski;Yuemang Yao.
The Journal of Neuroscience (2012)
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie.
Acta Neuropathologica (2007)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf;S.X. Xie;H. Hurtig;D. Weintraub.
Neurology (2010)
Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.
Felix Geser;Nicholas J. Brandmeir;Linda K. Kwong;Maria Martinez-Lage.
JAMA Neurology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Pennsylvania
University of Pennsylvania
Harvard University
University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
International School for Advanced Studies
University of California, Davis
University of Padua
Aswan University
University of Tehran
Harbin Institute of Technology
University of Oslo
University of Minnesota
University of Parma
Leibniz Association
Primary Children's Hospital
University of Colorado Hospital
University of California, San Diego
Wayne State University
University of Duisburg-Essen
Cornell University